{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-006539","form_type":"8-K","ticker":"LFMD","cik":"0000948320","company_name":"LifeMD, Inc.","filed_at":"2025-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.912310+00:00","generated_at":"2026-05-23T04:36:27.480464+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"LifeMD acquires Optimal Human Health MD assets for 100k shares; launches women's health vertical","bullets":["Acquired key assets from Optimal Human Health MD for 100,000 shares of common stock (50k at close, 50k at 1yr) plus earn-out.","Earn-out: up to 200k additional shares if patient/revenue milestones met (2,500/$2.5M or 5,000/$4.5M).","Dr. Doug Lucas joins LifeMD as VP, Female Health & Clinical Operations under 3-year employment agreement.","At least 75% of Optimal's employees accepted employment offers from LifeMD.","Women's health offering expected Summer 2025; addresses $60-70B market by 2030 per BCG."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-006539","json":"https://secwatch.observer/filing/0001641172-25-006539.json","markdown":"https://secwatch.observer/filing/0001641172-25-006539.md","text":"https://secwatch.observer/filing/0001641172-25-006539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/948320/000164117225006539/0001641172-25-006539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/948320/000164117225006539/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:36:27.480464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}